Agios Pharmaceuticals, Inc.
AGIO
$29.20
-$1.03-3.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.93% | -110.91% | -16.54% | -9.49% | -0.61% |
| Total Depreciation and Amortization | -7.39% | 2.16% | -20.97% | -5.19% | -2.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 83.64% | 101.31% | 114.66% | 39.79% | -49.84% |
| Change in Net Operating Assets | 90.08% | -100.51% | -18.18% | -25.94% | -926.09% |
| Cash from Operations | 27.75% | -4.67% | -6.25% | -11.64% | -83.71% |
| Capital Expenditure | -15.82% | -271.12% | -453.80% | -443.26% | -313.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 289.24% | 89.62% | 113.47% | -9.07% | -150.33% |
| Cash from Investing | 283.24% | -61.90% | 112.02% | -9.61% | -151.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.19% | 68.18% | -94.09% | -72.39% | 471.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.19% | 68.18% | -94.09% | -72.39% | 471.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.98% | -93.00% | 105.57% | -91.11% | -843.48% |